Ulinastatin, a human protease inhibitor and androstenediol, a metabolite of dihydroxystheniandrosterone, reduce plasma levels of TNF-α and IL-6 in rats with sepsis [60,61]. The gene discussed is TNF; the disease is Sepsis.